ChrysCap to buy 30% in Corona Remedies for Rs 670 cr

Homegrown private equity fund ChrysCapital will invest about Rs 670 crore ($90 million) to acquire about 30% stake in Ahmedabad-based drug manufacturer Corona Remedies.